Study of the experimental drug VK3019 for adults with overweight or obesity
Part of Hormones & metabolism clinical trials.
This early-phase study tests an experimental medicine called VK3019 in adults who are overweight or have obesity but are otherwise healthy. The goal is to see if the drug is safe and how the body handles it, which may lead to future weight-management options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult and generally healthy, with no major medical conditions.
- Your body mass index (BMI) is between 27 and 40 (this means overweight or obesity).
- You are willing to use effective birth control during the study if needed.
- You do not have diabetes (type 1 or type 2) now or in the past (except gestational diabetes).
- You do not have active liver or gallbladder disease (except Gilbert's syndrome).
- You have not had drug or alcohol abuse in the past year (alcohol limits: about 14 drinks per week for women, 21 for men).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a new once-weekly medication (VK2735) that may help with weight loss. It's for healthy adults with obesity who do not have other significant health problems like diabetes.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.
This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.
This study tests an oral medication (VK2735) that may help adults with obesity or overweight with weight-related health issues lose weight. Participants take the pill as part of the trial to see if it is safe and effective for weight management.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
Hear when a new Obese Adults trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.